Study for the Mechanism of the Relationship between Infection of novel coronavirus pneumonia (COVID-19) and Host Innate Immune

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000031627

Enrollment

Unknown

Registered

2020-04-05

Start date

2020-04-20

Completion date

Unknown

Last updated

2020-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Control group :Isolate PBMC to extract tRNA

normal group:Isolate PBMC to extract tRNA

severe group:Isolate PBMC to extract tRNA

Eligibility

Sex/Gender

All

Age

10 Years to 85 Years

Inclusion criteria

Inclusion criteria: Healthy group: healthy, without serious disease; normal group: diagnosed patients with common NCP; severe group: diagnosed patients with severe NCP.

Exclusion criteria

Exclusion criteria: Uninfected group: with severe disease of heart, liver, lung, kidney or other organs; normal group: those who refused to join this trial; severe group: those who refused to join this trial.

Design outcomes

Primary

Measure	Time frame
CRP;SAA;IL-6;PCT;tRNA;	—

Countries

China

Contacts

Public ContactXiuyong Li

2nd People's Hospital of Fuyang City

lxy7111@126.com+86 13505581239

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026